Viewing Study NCT01733004


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT01733004
Status: COMPLETED
Last Update Posted: 2016-08-04
First Post: 2012-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Sponsor: Merrimack Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Hepatocellular Carcinoma View
None Oncology View
None Phase I View
None ErbB3 View
None IGF-1R View
None Everolimus View
None Gemcitabine View
None Abraxane View